您的位置: 首页 > 农业专利 > 详情页

Use of Chymase Inhibitors for the Treatment of Endometriosis, Post-Operative Fibrosis and Diseases which are Characterized by Fibrosis Formation
专利权人:
BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
Michaele PETERS,Markus KOCH,Thomas ZOLLNER
申请号:
US16471928
公开号:
US20190381040A1
申请日:
2017.12.13
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present application relates to the use of bicyclic-substituted uracil derivatives, alone or in combinations with other active ingredients for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of inflammatory and fibrotic disorders, for the treatment of endometriosis, of endometriosis-associated fibrosis, of adenomyosis and of pain associated with an endometriosis disorder and also of postoperative peritoneal fibrosis and adhesion formation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充